Clinical trial
Bioequivalence Trial of a New Opioid Combination Compared to Reference
NCT00460785 · Grünenthal GmbH, Industry · Completed
Key facts
| NCT number | NCT00460785 |
|---|---|
| Title | Bioequivalence Trial of a New Opioid Combination Compared to Reference |
| Official title | Phase 1 Single Center Trial to Demonstrate the Bioequivalence of a New Combination Analgesic Formulation as Compared to an Equimolar Marketed Formulation |
| Lead sponsor | Grünenthal GmbH, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Opioid |
| Enrollment | 32 |
| Start date | Feb 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Apr 16, 2007 |
| Last update posted | Jul 6, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: